October 26, 2006 Analysis of paroxetine Yellow Card adverse drug reaction reports (Seroxat/Paxil)Analysis of paroxetine Yellow Card adverse drug reaction reports (Seroxat/Paxil) Thu, 20 Nov 2003 A unique analysis Read More Analysis of paroxetine Yellow Card adverse drug reaction reports (Seroxat/Paxil)
October 26, 2006 Featured NewsAHRP Speaks Out AHRP Press Briefing 9/14/04: Antidepressants & suicide-related risks for children Open Letter to NIMH Read More Featured News
October 26, 2006 ArticleLetter from David Healy, MD to Peter J. Pitts Executive Summary of suicidal evidence not addressed by Read More Article
October 26, 2006 800 people hooked on Paxil Sue in UKSeptember 16 2002 Note: Paroxetine Hydrochloride is also known as Seroxat or Paxil 800 hooked on drug Read More 800 people hooked on Paxil Sue in UK
October 26, 2006 Risks: Drugs / Vaccines / Trials / TreatmentsRisks: Drugs / Vaccines / Trials / Treatment Evidence of antidepressant harm Oct 14, 2005: Andrew Finkelstein Read More Risks: Drugs / Vaccines / Trials / Treatments
October 26, 2006 Unreported Paxil suicides: company abandons "No Addiction" claimUnreported Paxil suicides: company abandons “No Addiction” claim Sat, 10 May 2003 GlaxoSmithKline, Britain’s biggest pharmaceutical company Read More Unreported Paxil suicides: company abandons "No Addiction" claim
October 26, 2006 Time to put drug giants on trial – Scotsman (UK)Time to put drug giants on trial – Scotsman (UK) Fri, 20 Jun 2003 The UK media-including Read More Time to put drug giants on trial – Scotsman (UK)
March 1, 2006 UK-MHRA Drug-Related Suicide Reports_Yellow Card It is estimated to represent 1 in 100 adverse drug events that occur. However, as there is Read More UK-MHRA Drug-Related Suicide Reports_Yellow Card
April 26, 2004 VIOXX – Merck–MEDCO – a case studyVIOXX – Merck–MEDCO – a case study Wed, 13 Oct 2004 Vioxx: A case study in how Read More VIOXX – Merck–MEDCO – a case study
July 31, 2003 Infomail Archive 2003Infomail Archive 2003 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Dec 19, Read More Infomail Archive 2003